Association between serum 25-hydroxyvitamin D and global DNA methylation in visceral adipose tissue from colorectal cancer patients

Visceral adipose tissue (VAT) has been identified as the essential fat depot for pathogenetic theories that associateobesity and colon cancer. LINE-1 hypomethylation has been mostly detected in tumor colon tissue, but less is known about the epigenetic pattern in surrounding tissues. The aim was to...

Full description

Saved in:
Bibliographic Details
Published inBMC cancer Vol. 19; no. 1; pp. 93 - 7
Main Authors Castellano-Castillo, Daniel, Morcillo, Sonsoles, Crujeiras, Ana B., Sánchez-Alcoholado, Lidia, Clemente-Postigo, Mercedes, Torres, Esperanza, Tinahones, Francisco José, Macias-Gonzalez, Manuel
Format Journal Article
LanguageEnglish
Published England BioMed Central Ltd 21.01.2019
BioMed Central
BMC
Subjects
Online AccessGet full text
ISSN1471-2407
1471-2407
DOI10.1186/s12885-018-5226-4

Cover

Loading…
Abstract Visceral adipose tissue (VAT) has been identified as the essential fat depot for pathogenetic theories that associateobesity and colon cancer. LINE-1 hypomethylation has been mostly detected in tumor colon tissue, but less is known about the epigenetic pattern in surrounding tissues. The aim was to analyze for the first time the potential relationship between serum vitamin D, obesity and global methylation (LINE-1) in the visceral adipose tissue (VAT) from patients with and without colorectal cancer. A total of 55 patients with colorectal cancer and 35 control subjects participated in the study. LINE-1 DNA methylation in VAT was measured by pyrosequencing. Serum 25(OH)D levels were determined by ELISA. Cancer patients had lower levels of LINE-1 methylation in VAT compared with the control group. In the subjects with colorectal cancer, LINE-1 DNA methylation levels were associated positively with vitamin D levels (r = 0,463; p < 0.001) and negatively with BMI (r = - 0.334, p = 0.01) and HOMA insulin resistance index (r = - 0.348, p = 0.01). Serum vitamin D was the main variable explaining the LINE-1% variance in the cancer group (β = 0.460, p < 0.001). In a multivariate analysis, subjects with higher LINE-1 methylation values had lower risk of developing colorectal cancer (OR = 0.53; IC95% =0.28-0.99) compared with the control group. We showed for the first time an association between LINE-1 DNA methylation in VAT and vitamin D levels in subjects with colorectal cancer, highlighting the importance of VAT from cancer patients, which could be modified epigenetically compared to healthy subjects.
AbstractList Visceral adipose tissue (VAT) has been identified as the essential fat depot for pathogenetic theories that associateobesity and colon cancer. LINE-1 hypomethylation has been mostly detected in tumor colon tissue, but less is known about the epigenetic pattern in surrounding tissues. The aim was to analyze for the first time the potential relationship between serum vitamin D, obesity and global methylation (LINE-1) in the visceral adipose tissue (VAT) from patients with and without colorectal cancer. A total of 55 patients with colorectal cancer and 35 control subjects participated in the study. LINE-1 DNA methylation in VAT was measured by pyrosequencing. Serum 25(OH)D levels were determined by ELISA. Cancer patients had lower levels of LINE-1 methylation in VAT compared with the control group. In the subjects with colorectal cancer, LINE-1 DNA methylation levels were associated positively with vitamin D levels (r = 0,463; p < 0.001) and negatively with BMI (r = - 0.334, p = 0.01) and HOMA insulin resistance index (r = - 0.348, p = 0.01). Serum vitamin D was the main variable explaining the LINE-1% variance in the cancer group (β = 0.460, p < 0.001). In a multivariate analysis, subjects with higher LINE-1 methylation values had lower risk of developing colorectal cancer (OR = 0.53; IC95% =0.28-0.99) compared with the control group. We showed for the first time an association between LINE-1 DNA methylation in VAT and vitamin D levels in subjects with colorectal cancer, highlighting the importance of VAT from cancer patients, which could be modified epigenetically compared to healthy subjects.
Visceral adipose tissue (VAT) has been identified as the essential fat depot for pathogenetic theories that associateobesity and colon cancer. LINE-1 hypomethylation has been mostly detected in tumor colon tissue, but less is known about the epigenetic pattern in surrounding tissues. The aim was to analyze for the first time the potential relationship between serum vitamin D, obesity and global methylation (LINE-1) in the visceral adipose tissue (VAT) from patients with and without colorectal cancer.BACKGROUNDVisceral adipose tissue (VAT) has been identified as the essential fat depot for pathogenetic theories that associateobesity and colon cancer. LINE-1 hypomethylation has been mostly detected in tumor colon tissue, but less is known about the epigenetic pattern in surrounding tissues. The aim was to analyze for the first time the potential relationship between serum vitamin D, obesity and global methylation (LINE-1) in the visceral adipose tissue (VAT) from patients with and without colorectal cancer.A total of 55 patients with colorectal cancer and 35 control subjects participated in the study. LINE-1 DNA methylation in VAT was measured by pyrosequencing. Serum 25(OH)D levels were determined by ELISA.METHODSA total of 55 patients with colorectal cancer and 35 control subjects participated in the study. LINE-1 DNA methylation in VAT was measured by pyrosequencing. Serum 25(OH)D levels were determined by ELISA.Cancer patients had lower levels of LINE-1 methylation in VAT compared with the control group. In the subjects with colorectal cancer, LINE-1 DNA methylation levels were associated positively with vitamin D levels (r = 0,463; p < 0.001) and negatively with BMI (r = - 0.334, p = 0.01) and HOMA insulin resistance index (r = - 0.348, p = 0.01). Serum vitamin D was the main variable explaining the LINE-1% variance in the cancer group (β = 0.460, p < 0.001). In a multivariate analysis, subjects with higher LINE-1 methylation values had lower risk of developing colorectal cancer (OR = 0.53; IC95% =0.28-0.99) compared with the control group.RESULTSCancer patients had lower levels of LINE-1 methylation in VAT compared with the control group. In the subjects with colorectal cancer, LINE-1 DNA methylation levels were associated positively with vitamin D levels (r = 0,463; p < 0.001) and negatively with BMI (r = - 0.334, p = 0.01) and HOMA insulin resistance index (r = - 0.348, p = 0.01). Serum vitamin D was the main variable explaining the LINE-1% variance in the cancer group (β = 0.460, p < 0.001). In a multivariate analysis, subjects with higher LINE-1 methylation values had lower risk of developing colorectal cancer (OR = 0.53; IC95% =0.28-0.99) compared with the control group.We showed for the first time an association between LINE-1 DNA methylation in VAT and vitamin D levels in subjects with colorectal cancer, highlighting the importance of VAT from cancer patients, which could be modified epigenetically compared to healthy subjects.CONCLUSIONSWe showed for the first time an association between LINE-1 DNA methylation in VAT and vitamin D levels in subjects with colorectal cancer, highlighting the importance of VAT from cancer patients, which could be modified epigenetically compared to healthy subjects.
Abstract Background Visceral adipose tissue (VAT) has been identified as the essential fat depot for pathogenetic theories that associateobesity and colon cancer. LINE-1 hypomethylation has been mostly detected in tumor colon tissue, but less is known about the epigenetic pattern in surrounding tissues. The aim was to analyze for the first time the potential relationship between serum vitamin D, obesity and global methylation (LINE-1) in the visceral adipose tissue (VAT) from patients with and without colorectal cancer. Methods A total of 55 patients with colorectal cancer and 35 control subjects participated in the study. LINE-1 DNA methylation in VAT was measured by pyrosequencing. Serum 25(OH)D levels were determined by ELISA. Results Cancer patients had lower levels of LINE-1 methylation in VAT compared with the control group. In the subjects with colorectal cancer, LINE-1 DNA methylation levels were associated positively with vitamin D levels (r = 0,463; p < 0.001) and negatively with BMI (r = − 0.334, p = 0.01) and HOMA insulin resistance index (r = − 0.348, p = 0.01). Serum vitamin D was the main variable explaining the LINE-1% variance in the cancer group (β = 0.460, p < 0.001). In a multivariate analysis, subjects with higher LINE-1 methylation values had lower risk of developing colorectal cancer (OR = 0.53; IC95% =0.28–0.99) compared with the control group. Conclusions We showed for the first time an association between LINE-1 DNA methylation in VAT and vitamin D levels in subjects with colorectal cancer, highlighting the importance of VAT from cancer patients, which could be modified epigenetically compared to healthy subjects.
ArticleNumber 93
Audience Academic
Author Clemente-Postigo, Mercedes
Sánchez-Alcoholado, Lidia
Crujeiras, Ana B.
Torres, Esperanza
Morcillo, Sonsoles
Castellano-Castillo, Daniel
Tinahones, Francisco José
Macias-Gonzalez, Manuel
Author_xml – sequence: 1
  givenname: Daniel
  surname: Castellano-Castillo
  fullname: Castellano-Castillo, Daniel
– sequence: 2
  givenname: Sonsoles
  surname: Morcillo
  fullname: Morcillo, Sonsoles
– sequence: 3
  givenname: Ana B.
  surname: Crujeiras
  fullname: Crujeiras, Ana B.
– sequence: 4
  givenname: Lidia
  surname: Sánchez-Alcoholado
  fullname: Sánchez-Alcoholado, Lidia
– sequence: 5
  givenname: Mercedes
  surname: Clemente-Postigo
  fullname: Clemente-Postigo, Mercedes
– sequence: 6
  givenname: Esperanza
  surname: Torres
  fullname: Torres, Esperanza
– sequence: 7
  givenname: Francisco José
  surname: Tinahones
  fullname: Tinahones, Francisco José
– sequence: 8
  givenname: Manuel
  orcidid: 0000-0002-6475-4704
  surname: Macias-Gonzalez
  fullname: Macias-Gonzalez, Manuel
BackLink https://www.ncbi.nlm.nih.gov/pubmed/30665376$$D View this record in MEDLINE/PubMed
BookMark eNp1ktuL1DAUxousuBf9A3yRgCD60DW3Ns2LMOx6GVgUvDyHNDmdydI2Y5OuO8_-46Z2V6ai5CEh5_d95Jx8p9lR73vIsqcEnxNSla8DoVVV5JhUeUFpmfMH2QnhguSUY3F0cD7OTkO4xpiIClePsmOGy7JgojzJfq5C8Mbp6HyPaog_AHoUYBg7RIt8u7eDv93fuKg716NLpHuLNq2vdYsuP65QB3G7b2dxqt-4YGBINW3dzgdA0YUwAmoG3yHjWz-AialsdJ84tEtC6GN4nD1sdBvgyd1-ln179_brxYf86tP79cXqKjeFFDHXjAqOy5pbK2lNaqCSMkENE6lNqk3BbQ2YaMDa1pTXmJZU8lpXpbCkbBg7y9azr_X6Wu0G1-lhr7x26veFHzZKD9GZFpSUtWaEWMmw5SVwyUTTaG4JsEJqKZPXm9lrN9YdWJP6SI0vTJeV3m3Vxt-oknFSiMng5Z3B4L-PEKLqpum1re7Bj0FRIiTHsmQ4oc9ndKPT01zf-ORoJlytiopwWkgydXf-DyotC50zKTiNS_cLwauFIDERbuNGjyGo9ZfPS_bFAbsF3cZt8O04_XxYgs8O5_JnIPeJS4CYATP4EAZolEnpmnzSc12rCFZTttWcbZWyraZsK56U5C_lvfn_Nb8AWs36eA
CitedBy_id crossref_primary_10_1080_15592294_2021_1950991
crossref_primary_10_23736_S2724_6507_20_03299_X
crossref_primary_10_1155_2019_7406078
crossref_primary_10_1016_j_freeradbiomed_2022_10_003
crossref_primary_10_1007_s11888_021_00465_8
crossref_primary_10_3390_ijms21124484
crossref_primary_10_1002_mnfr_202100125
crossref_primary_10_7717_peerj_17105
crossref_primary_10_2147_TACG_S365613
crossref_primary_10_3390_jcm8071041
crossref_primary_10_1007_s11154_019_09522_y
crossref_primary_10_2217_epi_2022_0288
crossref_primary_10_1039_D0FO01984D
crossref_primary_10_3390_biom9070289
crossref_primary_10_1002_mco2_496
crossref_primary_10_1002_mnfr_202000437
crossref_primary_10_1016_j_jgg_2024_12_020
crossref_primary_10_1016_j_phanu_2020_100231
Cites_doi 10.1158/1078-0432.CCR-08-3330
10.1016/j.jnutbio.2004.08.004
10.3748/wjg.v20.i18.5177
10.1111/j.1749-6632.2011.06096.x
10.1017/S0007114516000696
10.1515/cclm-2012-0624
10.1007/s12263-015-0480-4
10.2174/0929867324666161117155325
10.1186/1471-2407-14-712
10.1371/journal.pone.0034615
10.1038/nrendo.2014.94
10.1038/ng0894-536
10.1136/gutjnl-2015-310912
10.1038/ng1834
10.1038/nrg2640
10.1093/nar/gki987
10.1158/1055-9965.EPI-14-1161
10.1002/mnfr.201400079
10.1093/jnci/dju195
10.4161/15592294.2014.969617
10.1158/1055-9965.EPI-08-0926
10.1136/gut.2004.054718
10.1136/gut.2005.073163
10.3389/fendo.2014.00065
10.1136/gut.2009.183707
10.1371/journal.pone.0109478
10.1136/gutjnl-2013-304701
10.1177/003335490912400320
10.1016/S2213-8587(14)70134-2
10.1007/s00384-003-0539-3
10.2217/epi.11.22
10.18632/oncotarget.10998
10.1016/S0140-6736(89)91789-3
10.1186/s13148-018-0493-0
10.1111/acel.12030
10.1016/j.jsbmb.2016.11.020
10.1186/1476-4598-9-125
10.1038/ijo.2014.34.
10.1016/j.mrfmmm.2012.02.005
10.1016/j.gastrohep.2012.01.002.
10.1038/s41366-018-0065-6
10.1186/1475-2891-10-51
10.18632/oncotarget.4450
10.1186/1868-7083-4-10
ContentType Journal Article
Copyright COPYRIGHT 2019 BioMed Central Ltd.
The Author(s). 2019
Copyright_xml – notice: COPYRIGHT 2019 BioMed Central Ltd.
– notice: The Author(s). 2019
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
ISR
7X8
5PM
DOA
DOI 10.1186/s12885-018-5226-4
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Gale In Context: Science
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE
MEDLINE - Academic

Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1471-2407
EndPage 7
ExternalDocumentID oai_doaj_org_article_99ba311d930d46e4937ffa4d1e359a99
PMC6341579
A581425913
30665376
10_1186_s12885_018_5226_4
Genre Journal Article
GrantInformation_xml – fundername: NICOLAS MONARDES SAS SPAIN
  grantid: C-0029-2014
– fundername: CIBERobn MINISTERIO DE SANIDAD ISCIII SPAIN
  grantid: CB06/03/0018
– fundername: ISCIII-FIS SPAIN
  grantid: PI11/01661
– fundername: CONSEJERIA INNOVACION JUNTA DE ANDALUCIA ,SPAIN
  grantid: PI11-CTS-8181
– fundername: FPU MINISTERIO EDUCACION SPAIN
  grantid: 13/04211
– fundername: ;
– fundername: ;
  grantid: PI11/01661
– fundername: ;
  grantid: CB06/03/0018
– fundername: ;
  grantid: 13/04211
– fundername: ;
  grantid: PI11-CTS-8181
– fundername: ;
  grantid: C-0029-2014
GroupedDBID ---
0R~
23N
2WC
53G
5VS
6J9
6PF
7X7
88E
8FI
8FJ
AAFWJ
AAJSJ
AASML
AAWTL
AAYXX
ABDBF
ABUWG
ACGFO
ACGFS
ACIHN
ACMJI
ACPRK
ACUHS
ADBBV
ADRAZ
ADUKV
AEAQA
AENEX
AFKRA
AFPKN
AHBYD
AHMBA
AHYZX
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIJS
BAPOH
BAWUL
BCNDV
BENPR
BFQNJ
BMC
BPHCQ
BVXVI
C6C
CCPQU
CITATION
CS3
DIK
DU5
E3Z
EAD
EAP
EAS
EBD
EBLON
EBS
EJD
EMB
EMK
EMOBN
ESX
F5P
FYUFA
GROUPED_DOAJ
GX1
H13
HMCUK
HYE
IAO
IHR
IHW
INH
INR
ISR
ITC
KQ8
M1P
M48
M~E
O5R
O5S
OK1
OVT
P2P
PGMZT
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
PSQYO
RBZ
RNS
ROL
RPM
RSV
SBL
SOJ
SV3
TR2
TUS
U2A
UKHRP
W2D
WOQ
WOW
XSB
-A0
3V.
ACRMQ
ADINQ
C24
CGR
CUY
CVF
ECM
EIF
NPM
PMFND
7X8
PPXIY
5PM
PJZUB
PUEGO
ID FETCH-LOGICAL-c597t-a327406b4dd92b1be292372c374712ac54dbe01ae0adb24b026294ba867d16f33
IEDL.DBID M48
ISSN 1471-2407
IngestDate Wed Aug 27 01:13:39 EDT 2025
Thu Aug 21 18:22:58 EDT 2025
Fri Jul 11 11:43:51 EDT 2025
Tue Jun 17 21:46:31 EDT 2025
Tue Jun 10 20:29:07 EDT 2025
Fri Jun 27 04:22:32 EDT 2025
Thu May 22 21:19:01 EDT 2025
Wed Feb 19 02:35:03 EST 2025
Tue Jul 01 03:06:13 EDT 2025
Thu Apr 24 22:51:54 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Obesity
Epigenetic
Vitamin D
Global DNA methylation
Colorectal cancer
Language English
License Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c597t-a327406b4dd92b1be292372c374712ac54dbe01ae0adb24b026294ba867d16f33
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0002-6475-4704
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.1186/s12885-018-5226-4
PMID 30665376
PQID 2179409630
PQPubID 23479
PageCount 7
ParticipantIDs doaj_primary_oai_doaj_org_article_99ba311d930d46e4937ffa4d1e359a99
pubmedcentral_primary_oai_pubmedcentral_nih_gov_6341579
proquest_miscellaneous_2179409630
gale_infotracmisc_A581425913
gale_infotracacademiconefile_A581425913
gale_incontextgauss_ISR_A581425913
gale_healthsolutions_A581425913
pubmed_primary_30665376
crossref_citationtrail_10_1186_s12885_018_5226_4
crossref_primary_10_1186_s12885_018_5226_4
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2019-01-21
PublicationDateYYYYMMDD 2019-01-21
PublicationDate_xml – month: 01
  year: 2019
  text: 2019-01-21
  day: 21
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
– name: London
PublicationTitle BMC cancer
PublicationTitleAlternate BMC Cancer
PublicationYear 2019
Publisher BioMed Central Ltd
BioMed Central
BMC
Publisher_xml – name: BioMed Central Ltd
– name: BioMed Central
– name: BMC
References JP Issa (5226_CR11) 1994; 7
5226_CR9
U Hübner (5226_CR44) 2013; 51
M Pufulete (5226_CR45) 2005; 54
EE Frezza (5226_CR8) 2006; 55
CM Suter (5226_CR14) 2004; 19
D Castellano-Castillo (5226_CR27) 2018; 10
5226_CR29
T Shanmugalingam (5226_CR40) 2014; 14
5226_CR3
HS Tapp (5226_CR43) 2013; 12
5226_CR26
M Barchitta (5226_CR31) 2014; 9
5226_CR22
PG Vashi (5226_CR25) 2011; 10
M Bardou (5226_CR5) 2013; 62
JC Figueiredo (5226_CR39) 2009; 18
5226_CR24
V Nair-Shalliker (5226_CR42) 2012; 733
5226_CR41
AI Pérez-Hernández (5226_CR10) 2014; 5
JA Alegria-Torres (5226_CR15) 2011; 3
AE Harvey (5226_CR7) 2011; 1229
R Dou (5226_CR20) 2016; 115
DJ Weisenberger (5226_CR23) 2015; 24
DJ Weisenberger (5226_CR21) 2006; 38
JD Morillas (5226_CR4) 2012; 35
AJ Cox (5226_CR1) 2015; 3
J Park (5226_CR6) 2014; 10
AM Oommen (5226_CR16) 2005; 16
HD Woo (5226_CR36) 2012; 7
ES Schernhammer (5226_CR17) 2010; 59
S Ogino (5226_CR35) 2009; 15
DJ Weisenberger (5226_CR12) 2005; 33
S Riondino (5226_CR2) 2014; 20
5226_CR38
5226_CR33
5226_CR32
5226_CR13
R Cordaux (5226_CR34) 2009; 10
A Agodi (5226_CR18) 2015; 10
GM Martín-Núñez (5226_CR19) 2014; 58
C Zhuo (5226_CR37) 2015; 6
GM Martín-Núñez (5226_CR28) 2014; 9
V Turcot (5226_CR30) 2012; 4
References_xml – volume: 15
  start-page: 4431
  year: 2009
  ident: 5226_CR35
  publication-title: Clin Cancer Res
  doi: 10.1158/1078-0432.CCR-08-3330
– volume: 16
  start-page: 74
  year: 2005
  ident: 5226_CR16
  publication-title: J Nutr Biochem
  doi: 10.1016/j.jnutbio.2004.08.004
– volume: 20
  start-page: 5177
  year: 2014
  ident: 5226_CR2
  publication-title: World J Gastroenterol
  doi: 10.3748/wjg.v20.i18.5177
– volume: 1229
  start-page: 45
  year: 2011
  ident: 5226_CR7
  publication-title: Ann N Y Acad Sci
  doi: 10.1111/j.1749-6632.2011.06096.x
– volume: 115
  start-page: 1643
  year: 2016
  ident: 5226_CR20
  publication-title: Br J Nutr
  doi: 10.1017/S0007114516000696
– volume: 51
  start-page: 649
  year: 2013
  ident: 5226_CR44
  publication-title: Clin Chem Lab Med
  doi: 10.1515/cclm-2012-0624
– volume: 10
  start-page: 30
  year: 2015
  ident: 5226_CR18
  publication-title: Genes Nutr
  doi: 10.1007/s12263-015-0480-4
– ident: 5226_CR41
  doi: 10.2174/0929867324666161117155325
– volume: 14
  start-page: 712
  year: 2014
  ident: 5226_CR40
  publication-title: BMC Cancer
  doi: 10.1186/1471-2407-14-712
– volume: 7
  start-page: e34615
  year: 2012
  ident: 5226_CR36
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0034615
– volume: 10
  start-page: 455
  year: 2014
  ident: 5226_CR6
  publication-title: Nat Rev Endocrinol
  doi: 10.1038/nrendo.2014.94
– volume: 7
  start-page: 536
  year: 1994
  ident: 5226_CR11
  publication-title: Nat Genet
  doi: 10.1038/ng0894-536
– ident: 5226_CR3
  doi: 10.1136/gutjnl-2015-310912
– volume: 38
  start-page: 787
  year: 2006
  ident: 5226_CR21
  publication-title: Nat Genet
  doi: 10.1038/ng1834
– volume: 10
  start-page: 691
  year: 2009
  ident: 5226_CR34
  publication-title: Nat Rev Genet
  doi: 10.1038/nrg2640
– volume: 33
  start-page: 6823
  year: 2005
  ident: 5226_CR12
  publication-title: Nucleic Acids Res
  doi: 10.1093/nar/gki987
– volume: 24
  start-page: 512
  year: 2015
  ident: 5226_CR23
  publication-title: Cancer Epidemiol Biomark Prev
  doi: 10.1158/1055-9965.EPI-14-1161
– volume: 58
  start-page: 1528
  year: 2014
  ident: 5226_CR19
  publication-title: Mol Nutr Food Res
  doi: 10.1002/mnfr.201400079
– ident: 5226_CR13
  doi: 10.1093/jnci/dju195
– volume: 9
  start-page: 1322
  year: 2014
  ident: 5226_CR28
  publication-title: Epigenetics
  doi: 10.4161/15592294.2014.969617
– volume: 18
  start-page: 1041
  year: 2009
  ident: 5226_CR39
  publication-title: Cancer Epidemiol Biomark Prev
  doi: 10.1158/1055-9965.EPI-08-0926
– volume: 54
  start-page: 648
  year: 2005
  ident: 5226_CR45
  publication-title: Gut
  doi: 10.1136/gut.2004.054718
– volume: 55
  start-page: 285
  year: 2006
  ident: 5226_CR8
  publication-title: Gut
  doi: 10.1136/gut.2005.073163
– volume: 5
  start-page: 65
  year: 2014
  ident: 5226_CR10
  publication-title: Front Endocrinol (Lausanne)
  doi: 10.3389/fendo.2014.00065
– volume: 59
  start-page: 794
  year: 2010
  ident: 5226_CR17
  publication-title: Gut
  doi: 10.1136/gut.2009.183707
– ident: 5226_CR38
– volume: 9
  start-page: e109478
  year: 2014
  ident: 5226_CR31
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0109478
– volume: 62
  start-page: 933
  year: 2013
  ident: 5226_CR5
  publication-title: Gut
  doi: 10.1136/gutjnl-2013-304701
– ident: 5226_CR29
  doi: 10.1177/003335490912400320
– volume: 3
  start-page: 207
  year: 2015
  ident: 5226_CR1
  publication-title: Lancet Diabetes Endocrinol
  doi: 10.1016/S2213-8587(14)70134-2
– volume: 19
  start-page: 95
  year: 2004
  ident: 5226_CR14
  publication-title: Int J Color Dis
  doi: 10.1007/s00384-003-0539-3
– volume: 3
  start-page: 267
  year: 2011
  ident: 5226_CR15
  publication-title: Epigenomics
  doi: 10.2217/epi.11.22
– ident: 5226_CR9
  doi: 10.18632/oncotarget.10998
– ident: 5226_CR24
  doi: 10.1016/S0140-6736(89)91789-3
– volume: 10
  start-page: 60
  year: 2018
  ident: 5226_CR27
  publication-title: Clin Epigenetics
  doi: 10.1186/s13148-018-0493-0
– volume: 12
  start-page: 148
  year: 2013
  ident: 5226_CR43
  publication-title: Aging Cell
  doi: 10.1111/acel.12030
– ident: 5226_CR26
  doi: 10.1016/j.jsbmb.2016.11.020
– ident: 5226_CR33
  doi: 10.1186/1476-4598-9-125
– ident: 5226_CR32
  doi: 10.1038/ijo.2014.34.
– volume: 733
  start-page: 50
  year: 2012
  ident: 5226_CR42
  publication-title: Mutat Res Mol Mech Mutagen
  doi: 10.1016/j.mrfmmm.2012.02.005
– volume: 35
  start-page: 109
  year: 2012
  ident: 5226_CR4
  publication-title: Gastroenterol Hepatol
  doi: 10.1016/j.gastrohep.2012.01.002.
– ident: 5226_CR22
  doi: 10.1038/s41366-018-0065-6
– volume: 10
  start-page: 51
  year: 2011
  ident: 5226_CR25
  publication-title: Nutr J
  doi: 10.1186/1475-2891-10-51
– volume: 6
  start-page: 23820
  year: 2015
  ident: 5226_CR37
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.4450
– volume: 4
  start-page: 10
  year: 2012
  ident: 5226_CR30
  publication-title: Clin Epigenetics
  doi: 10.1186/1868-7083-4-10
SSID ssj0017808
Score 2.3454015
Snippet Visceral adipose tissue (VAT) has been identified as the essential fat depot for pathogenetic theories that associateobesity and colon cancer. LINE-1...
Abstract Background Visceral adipose tissue (VAT) has been identified as the essential fat depot for pathogenetic theories that associateobesity and colon...
SourceID doaj
pubmedcentral
proquest
gale
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 93
SubjectTerms Adipose tissues
Aged
Care and treatment
Colorectal cancer
Colorectal Neoplasms - blood
Colorectal Neoplasms - genetics
Development and progression
DNA Methylation
Enzyme-Linked Immunosorbent Assay
Epigenetic
Female
Global DNA methylation
Humans
Intra-Abdominal Fat - metabolism
Long Interspersed Nucleotide Elements - genetics
Male
Middle Aged
Multivariate Analysis
Obesity
Obesity - blood
Obesity - genetics
Risk factors
Sequence Analysis, DNA
Vitamin D
Vitamin D - analogs & derivatives
Vitamin D - blood
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3daxQxEA_SB_FF_Ha1ahRBEEI3m-xu8nhaSxXaB7XQt5CvtQt2r3T3Cn3uP96Z3dxxi6Avvl7m4DIzmZnfZeYXQt5rHMjkuWVN4CWTtdNM29Iy7TwAjKYp7UhffHRcHZ7Ib6fl6dZTX9gTNtEDT4rb09pZwXnQIg-yihLSadNYGXgUpbZ6HN2DnLcGU-n-oFa5SneYXFV7PURhhU1qimG9weQsC41k_X-G5K2cNO-X3EpABw_I_VQ50sX0ix-SO7F7RO4epbvxx-RmS9M0tV9RcLDVOS1KdnYdsGHlqh3sedvRfWq7QCc2ELp_vKD4kvT11BdHYf2q7T3-W0VtaC-WfaTDaCCK0ygUia4xUMKyR6e5pImdtX9CTg6-_Px8yNITC8wDkhiYFYBK88rJEHThuIsFFHx14QVi1cL6UgYXc25jboMrpAPEVmjprKrqwKtGiKdkp1t28TmhqgHwlmvrZQDIxyvnuPI197qBeOqkyEi-VrnxiX8cn8H4bUYcoiozWcmAlQxayciMfNx85WIi3_ib8Ce040YQebPHD8CbTPIm8y9vysgb9AIzDaFuTr9ZlIpDdNMctvFulEDujA6bc37ZVd-brz--z4Q-JKFmCXv0Ns06gKaQbmsmuTuThMPtZ8tv1-5ocAk74rq4XPWmwEgK-FPkGXk2uedm6wLv0yBzZKSeOe5MN_OVrj0bucUrqGrKWr_4H8p8Se5BHMB2PFbwXbIzXK7iKyjhBvd6PK23eOBCag
  priority: 102
  providerName: Directory of Open Access Journals
Title Association between serum 25-hydroxyvitamin D and global DNA methylation in visceral adipose tissue from colorectal cancer patients
URI https://www.ncbi.nlm.nih.gov/pubmed/30665376
https://www.proquest.com/docview/2179409630
https://pubmed.ncbi.nlm.nih.gov/PMC6341579
https://doaj.org/article/99ba311d930d46e4937ffa4d1e359a99
Volume 19
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1bi9NAFB72AuKLeLe61lEEQYibSSaXeRBp3V1WoUWqheLLMJdkt7Cbrk272Gf_uOdMprXBRXzJQ-c0MHPuOWe-Q8hrgRcyWaiC0rIk4JkWgVCJCoQ2kGCUZaIcfPFgmJ6O-edJMtkh6_FW_gDrG1M7nCc1nl-8-_lj9QEU_r1T-Dw9rMHG5tiClgcYTQR8l-yDY8pQTwf8T1Ehy92AOgb2GIsKmS9y3viKlptyaP5_2-wtp9VuqNzyUCd3yR0fWtJeIwv3yE5R3Se3Br54_oD82mIF9f1ZFCRweUmjJDhfWexouZ4u1OW0okdUVZY2cCH0aNijOGp61TTOUVi_ntYGP2dRZadXs7qgC8dBitdVKCJhoyWFZYNSNacevrV-SMYnx98-ngZ-BkNgINVYBCqGtDVMNbdWRJrpIoKIMItMjMlspEzCrS5CpopQWR1xDSldJLhWeZpZlpZx_IjsVbOqeEJoXkJ2FwpluIWckKVas9xkzIgSDK7mcYeE6yOXxgOU45yMC-kSlTyVDZckcEkilyTvkLebv1w16Bz_Iu4jHzeECKztfpjNz6TXUymEVjFjVsSh5WnBIXorS8UtK-JEKCE65AVKgWxuqW7Mg-wlOQPzJxhs45WjQHCNCrt3ztSyruWnr6MW0RtPVM5gj0b5yxBwUojH1aI8aFGC9pvW8su1OEpcwpa5qpgtaxmhqYUENQ475HEjnputx1hwA9fSIVlLcFtn016ppucOfDyFsCfJxNP_2eUzchsMAfbjBRE7IHuL-bJ4DjHcQnfJbjbJumS_fzz8Muq6LyFdp63wHPW__wZcmEVy
linkProvider Scholars Portal
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Association+between+serum+25-hydroxyvitamin+D+and+global+DNA+methylation+in+visceral+adipose+tissue+from+colorectal+cancer+patients&rft.jtitle=BMC+cancer&rft.au=Castellano-Castillo%2C+Daniel&rft.au=Morcillo%2C+Sonsoles&rft.au=Crujeiras%2C+Ana+B&rft.au=Sanchez-Alcoholado%2C+Lidia&rft.date=2019-01-21&rft.pub=BioMed+Central+Ltd&rft.issn=1471-2407&rft.eissn=1471-2407&rft.volume=19&rft.issue=1&rft_id=info:doi/10.1186%2Fs12885-018-5226-4&rft.externalDBID=ISR&rft.externalDocID=A581425913
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-2407&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-2407&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-2407&client=summon